Cargando…
Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells
PURPOSE: Lipocalin 2 (LCN2) is a secretory protein that is involved in various physiological processes including iron transport. We previously identified LCN2 as an up-regulated gene in endometrial carcinoma, and found that the overexpression of LCN2 and its receptor, SLC22A17, was associated with a...
Autores principales: | Miyamoto, Tsutomu, Kashima, Hiroyasu, Yamada, Yasushi, Kobara, Hisanori, Asaka, Ryoichi, Ando, Hirofumi, Higuchi, Shotaro, Ida, Koichi, Mvunta, David Hamisi, Shiozawa, Tanri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864227/ https://www.ncbi.nlm.nih.gov/pubmed/27168162 http://dx.doi.org/10.1371/journal.pone.0155220 |
Ejemplares similares
-
SIRT1 Regulates the Chemoresistance and Invasiveness of Ovarian Carcinoma Cells()
por: Mvunta, David Hamisi, et al.
Publicado: (2017) -
A case of pure-type ovarian squamous cell carcinoma producing granulocyte-colony stimulating factor
por: Kobara, Hisanori, et al.
Publicado: (2017) -
Limited frequency of malignant change in lobular endocervical glandular hyperplasia
por: Kobara, Hisanori, et al.
Publicado: (2020) -
Biology and management of lobular endocervical glandular hyperplasia
por: Miyamoto, Tsutomu, et al.
Publicado: (2022) -
Cyclin A2 confers cisplatin resistance to endometrial carcinoma cells via up-regulation of an Akt-binding protein, periplakin
por: Suzuki, Akihisa, et al.
Publicado: (2010)